NL163119C - PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-LEUKEMIC ACTION AND PROCESS FOR PREPARING A 1- (2-HALOGENETHYL) -1-NITROSO-UREUM COMPOUND. - Google Patents

PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-LEUKEMIC ACTION AND PROCESS FOR PREPARING A 1- (2-HALOGENETHYL) -1-NITROSO-UREUM COMPOUND.

Info

Publication number
NL163119C
NL163119C NL7215698A NL7215698A NL163119C NL 163119 C NL163119 C NL 163119C NL 7215698 A NL7215698 A NL 7215698A NL 7215698 A NL7215698 A NL 7215698A NL 163119 C NL163119 C NL 163119C
Authority
NL
Netherlands
Prior art keywords
preparing
halogenethyl
ureum
nitroso
compound
Prior art date
Application number
NL7215698A
Other languages
Dutch (nl)
Other versions
NL163119B (en
NL7215698A (en
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9348571A external-priority patent/JPS5033072B2/ja
Priority claimed from JP9803471A external-priority patent/JPS5125030B2/ja
Priority claimed from JP7478272A external-priority patent/JPS5425027B2/ja
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NL7215698A publication Critical patent/NL7215698A/xx
Publication of NL163119B publication Critical patent/NL163119B/en
Application granted granted Critical
Publication of NL163119C publication Critical patent/NL163119C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL7215698A 1971-11-20 1972-11-20 PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-LEUKEMIC ACTION AND PROCESS FOR PREPARING A 1- (2-HALOGENETHYL) -1-NITROSO-UREUM COMPOUND. NL163119C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9348571A JPS5033072B2 (en) 1971-11-20 1971-11-20
JP9803471A JPS5125030B2 (en) 1971-12-04 1971-12-04
JP7478272A JPS5425027B2 (en) 1972-07-26 1972-07-26

Publications (3)

Publication Number Publication Date
NL7215698A NL7215698A (en) 1973-05-22
NL163119B NL163119B (en) 1980-03-17
NL163119C true NL163119C (en) 1980-08-15

Family

ID=27301617

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7215698A NL163119C (en) 1971-11-20 1972-11-20 PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-LEUKEMIC ACTION AND PROCESS FOR PREPARING A 1- (2-HALOGENETHYL) -1-NITROSO-UREUM COMPOUND.

Country Status (7)

Country Link
BE (1) BE791647A (en)
CH (1) CH576443A5 (en)
DE (1) DE2257360C2 (en)
DK (1) DK134909B (en)
FR (1) FR2160594B1 (en)
GB (1) GB1374344A (en)
NL (1) NL163119C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8526154D0 (en) * 1985-02-06 1985-11-27 Kotobuki Seiyaku Co Ltd 2-substituted cyclo-heptoimidazoles

Also Published As

Publication number Publication date
CH576443A5 (en) 1976-06-15
BE791647A (en) 1973-05-21
NL163119B (en) 1980-03-17
FR2160594B1 (en) 1976-05-21
DK134909C (en) 1977-07-04
DK134909B (en) 1977-02-07
DE2257360C2 (en) 1982-03-11
DE2257360A1 (en) 1973-05-24
FR2160594A1 (en) 1973-06-29
GB1374344A (en) 1974-11-20
NL7215698A (en) 1973-05-22

Similar Documents

Publication Publication Date Title
NL172511B (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINE AGAINST INFLAMMATION
NL175491C (en) METHOD FOR PREPARING A MEAT-PROTEIN PRODUCT
NL174550C (en) METHOD FOR PREPARING AN INACTION-ANTI-COMPOSITION COMPOUND, METHOD FOR PREPARING A MEDICINE WITH AN INACTION-ANTI-OPERATING ACTION AND FORMED MEDICINE
NL139166B (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH BETA ADRENERGIC BLOCKING ACTION.
NL173641C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT
NL142672B (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH A CHOLESTEROL MIRROR-LOWERING ACTION, AND METHOD OF PREPARING MEDICINAL COMPOUNDS THEREFORE.
NL169262C (en) PROCESS FOR PRESERVATING VEGETABLE PRODUCTS AND PROCESS FOR PREPARING A PRESERVATOR USED THEREIN
NL143924B (en) METHOD OF PREPARING A MEDICINAL PRODUCT AGAINST HYPERTENSION.
NL172653C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANTIMYCOTIC ACTION AND METHOD FOR PREPARING MEDICINAL IODINE PROPARGYLOXYARENE DERIVATIVES
NL149797B (en) PROCESS FOR PREPARING A CARBAMOYL GROUP CONTAINING OXAZOLE DERIVATIVE WITH ANTI-INFLAMMATORY ACTION AND A PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING THIS COMPOUND AND CONTAINING THIS COMPOUND.
NL150436B (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH ANOREXIGENIC ACTION.
NL170733C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT AND METHOD FOR PREPARING A MEDICINAL COMPOUND
NL141188B (en) METHOD OF PREPARING A MEDICINAL PRODUCT.
NL7612610A (en) PROCEDURE FOR PREPARING IMIDAZOLE COMPOUNDS AND PROCEDURE FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-URICOPATHETIC ACTION.
NL163119C (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-LEUKEMIC ACTION AND PROCESS FOR PREPARING A 1- (2-HALOGENETHYL) -1-NITROSO-UREUM COMPOUND.
NL175721C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT WITH ANTICHOLINERGIC ACTION
NL161150C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT, AND FORMED MEDICINAL PRODUCT AND METHOD FOR PREPARING A BENZOFURAN COMPOUND
NL138934B (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY ACTION.
NL174944C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT WITH ANTIBIOTIC EFFICACY, AND METHOD FOR PREPARING A HETACILLINE COMPOUND
NL161443C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT, AND METHOD FOR PREPARING A 2- (AMINOPHENETHYL) PIPERIDINE COMPOUND
NL171806C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANALGETIC AND / OR ANTI-COUGHING ACTION, AND METHOD FOR PREPARING A BENZAZONINE COMPOUND
NL175825C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT WITH ANTILIPIDEMIC ACTION
NL149162B (en) PROCEDURE FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY AND ANTI-PAIN ACTION.
NL151073B (en) PROCESS FOR THE SELF-KNOWN PREPARATION OF A MEDICINAL PRODUCT WITH ANALGETIC ACTION, CONTAINING PREPARED MEDICINAL PRODUCTS, AND A PROCESS FOR PREPARING 3-AMINO-1,2,3,4-TETRAH-ZOO.
NL152539B (en) METHOD FOR PREPARING A PREPARATION WITH HYPOCHOLESTEROLEMIC ACTION, FORMED PREPARATION AND PROCEDURE FOR PREPARING MEDICINAL COMPOUNDS.

Legal Events

Date Code Title Description
V4 Lapsed because of reaching the maxim lifetime of a patent